EDAP TMS Reports Clinical Results at 7 Years.

Publication: PR Newswire

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2005 PR Newswire Association LLC

84% of Study Participants Cancer Free With No Additional Treatment; Lower Side Effects Observed in 8 Year Study

LYON, France, Oct. 31 /PRNewswire-FirstCall/ -- EDAP TMS S.A. , presented advanced clinical data on the success of HIFU with Ablatherm(R) at the ISTU congress held at Harvard Medical School in Boston, MA.

The 5th International Symposium on Therapeutic Ultrasound (ISTU) was held in the Conference Center at Harvard Medical School. Its goals, both scientific and educational, are to assess the current state-of-the-art in therapeutic ultrasound, to foster communication among diverse multidisciplinary fields, to identify key problems and their solutions, to provide an overview and basic background for clinical uses of ultrasound therapy, and to share insights among researchers, clinical users and device manufacturers.

ISTU confirmed that several thousand patients with...

Read the full article for free courtesy of your local library.